Shen A, Arbesman M, Newell D, Chen J, et al. Germline Pathogenic Variants (gPVs) and Immune-Related Adverse Events (IRAEs) in Patients with Melanoma Receiving Immune Checkpoint Inhibitors (ICI). J Am Acad Dermatol 2025 Sep 2:S0190-9622(25)02743.
PMID: 40907766